BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer. [electronic resource]
Producer: 20100707Description: 1293-4 p. digitalISSN:- 1432-1335
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.